Research Paper Volume 15, Issue 7 pp 2503—2524
NCAPG as a novel prognostic biomarker in numerous cancers: a meta-analysis and bioinformatics analysis
Figure 8. DNA methylation features of NCAPG in BRCA (A), GBM (B), LIHC (C), LUAD (D), LUSC (E) and STAD (F). Phosphorylation of NCAPG in several selected cancers according to the CPTAC database. (G) The schematic diagram and phosphorylation sites of the NCAPG protein are shown. The phosphorylation of NCAPG at S674, S973, S975 and 984 in BRCA (H–J), S674 in GBM (K), S674 in LIHC (L), S674 in LUAD (M). The P53 pathway phosphorylation of NCAPG at S674, S973, S975 and 984 in BRCA (N–P), S674 in GBM (Q), S674 in LUAD (R), from the UALCAN database. *p < 0:05, **p < 0:01, and ***p < 0:001, Abbreviation: ns: No statistical significance.